檢索結果 - Shanthakumar Tyavanagimatt

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Development of ST-246® for Treatment of Poxvirus Infections

    Development of ST-246® for Treatment of Poxvirus Infections 由 Robert Jordan, Janet M. Leeds, Shanthakumar Tyavanagimatt, Dennis E. Hruby

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor

    Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor 由 Robert Jordan, Deborah Tien, Tové C. Bolken, Kevin F. Jones, Shanthakumar Tyavanagimatt, Josef Strasser, Annie Frimm, Michael L. Corrado, Phoebe G. Strome, Dennis E. Hruby

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    A potent Lassa virus antiviral targets an arenavirus virulence determinant

    A potent Lassa virus antiviral targets an arenavirus virulence determinant 由 Ikenna G. Madu, Megan Files, Dima Gharaibeh, Amy L. Moore, Kie-Hoon Jung, Brian B. Gowen, Dongcheng Dai, Kevin F. Jones, Shanthakumar Tyavanagimatt, James R. Burgeson, Marcus J. Korth, Kristin Bedard, Shawn P. Iadonato, Sean M. Amberg

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

    A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein 由 Chelsea M. Byrd, Dongcheng Dai, Douglas W. Grosenbach, Aklile Berhanu, Kevin F. Jones, Kara B. Cardwell, Christine A. Schneider, Kristin A. Wineinger, Jessica Pagé, Chris Harver, Eric Stavale, Shanthakumar Tyavanagimatt, Melialani A. Stone, Ralf Bartenschlager, Pietro Scaturro, Dennis E. Hruby, Robert Jordan

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers

    Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers 由 Jarasvech Chinsangaram, Kady M. Honeychurch, Shanthakumar Tyavanagimatt, Janet M. Leeds, Tové C. Bolken, Kevin F. Jones, Robert Jordan, Thomas Marbury, Jon Ruckle, Denis Mee-Lee, Eric A. Ross, Israel Lichtenstein, Margaret Pickens, Michael L. Corrado, Jean Μ. Clarke, Annie Frimm, Dennis E. Hruby

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis

    Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis 由 Stephen T. Oh, Ruben A. Mesa, Claire Harrison, Prithviraj Bose, Aaron T. Gerds, Vikas Gupta, Bart L. Scott, Jean‐Jacques Kiladjian, Alessandro Lucchesi, Tim Kong, Sarah Buckley, Shanthakumar Tyavanagimatt, Bryan Harder, Karisse Roman‐Torres, Jennifer A. Smith, Adam R. Craig, John Mascarenhas, Srđan Verstovšek

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification

    ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification 由 Robert Jordan, Arthur J. Goff, Annie Frimm, Michael L. Corrado, Lisa E. Hensley, Chelsea M. Byrd, Eric M. Mucker, Josh Shamblin, Tové C. Bolken, Carly Wlazlowski, Wendy Johnson, Jennifer Chapman, Nancy Twenhafel, Shanthakumar Tyavanagimatt, Adams Amantana, Jarasvech Chinsangaram, Dennis E. Hruby, John W. Huggins

    出版 2009
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase

    Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase 由 Chelsea M. Byrd, Douglas W. Grosenbach, Aklile Berhanu, Dongcheng Dai, Kevin F. Jones, Kara B. Cardwell, Christine A. Schneider, Guang Yang, Shanthakumar Tyavanagimatt, Chris Harver, Kristin A. Wineinger, Jessica Pagé, Eric Stavale, Melialani A. Stone, Kathleen Fuller, Candace Lovejoy, Janet M. Leeds, Dennis E. Hruby, Robert Jordan

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis

    Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis 由 Aaron T. Gerds, Michael R. Savona, Bart L. Scott, Moshe Talpaz, Miklós Egyed, Claire Harrison, Abdulraheem Yacoub, Alessandro M. Vannucchi, Adam J. Mead, Jean‐Jacques Kiladjian, Jennifer O’Sullivan, Valentín García‐Gutiérrez, Prithviraj Bose, Raajit K. Rampal, Carole B. Miller, Jeanne Palmer, Stephen T. Oh, Sarah Buckley, Diane R. Mould, Kaori Ito, Shanthakumar Tyavanagimatt, Jennifer A. Smith, Karisse Roman‐Torres, Sri Devineni, Adam R. Craig, John Mascarenhas

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: